Expired Canadian patentCanada
Therapeutic use of enkephalinase
CA 1322160 C · Owner: Genentech, Inc. · Inventors: Borson, Daniel Benjamin; Nadel, Jay Alan; Malfroy-Camine, Bernard
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method and therapeutic composition for the treatment of pathological disorders associated with endogenous peptides by the administration of enkephalinase or derivatives thereof. LG8x396.mhg
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 14, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 14, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 23, 1987
GrantedSeptember 14, 1993
Term endedSeptember 14, 2010
Patent numberCA 1322160 C
Classification (IPC)A61K38/46 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.